See more : Little Green Pharma Ltd (LGP.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Aarey Drugs & Pharmaceuticals Limited (AREYDRG.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aarey Drugs & Pharmaceuticals Limited, a leading company in the industry within the sector.
You may be interested
- Five Star Senior Living Inc. (FVE) Income Statement Analysis – Financial Results
- Lancashire Holdings Limited (LCSHF) Income Statement Analysis – Financial Results
- Libero Copper & Gold Corporation (LBCMF) Income Statement Analysis – Financial Results
- YNH Property Bhd (3158.KL) Income Statement Analysis – Financial Results
- Independence Gold Corp. (IGO.V) Income Statement Analysis – Financial Results
Aarey Drugs & Pharmaceuticals Limited (AREYDRG.BO)
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 4.18B | 4.92B | 3.48B | 2.98B | 3.54B |
| Cost of Revenue | 4.06B | 4.75B | 3.39B | 2.91B | 3.42B |
| Gross Profit | 115.07M | 169.54M | 89.17M | 61.79M | 121.14M |
| Gross Profit Ratio | 2.76% | 3.45% | 2.56% | 2.08% | 3.42% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 42.83M | 69.79M | 50.34M | 38.10M | 42.17M |
| Other Expenses | 22.32M | 17.99M | -137.41K | -165.40K | -9.98M |
| Operating Expenses | 20.51M | 51.80M | 50.48M | 38.26M | 52.16M |
| Cost & Expenses | 4.08B | 4.80B | 3.44B | 2.95B | 3.48B |
| Interest Income | 127.00K | 666.00K | 24.25M | 26.15M | 0.00 |
| Interest Expense | 28.67M | 20.37M | 24.43M | 17.85M | 22.30M |
| Depreciation & Amortization | -15.74M | -19.88M | -9.20M | -8.94M | -10.08M |
| EBITDA | 110.30M | 137.63M | 47.89M | 32.47M | 79.07M |
| EBITDA Ratio | 2.64% | 2.80% | 1.38% | 1.09% | 2.23% |
| Operating Income | 94.56M | 117.74M | 38.69M | 23.53M | 68.99M |
| Operating Income Ratio | 2.26% | 2.39% | 1.11% | 0.79% | 1.95% |
| Total Other Income/Expenses | -34.47M | -17.37M | 44.32M | 48.90M | 20.87M |
| Income Before Tax | 60.10M | 100.37M | 83.01M | 72.42M | 89.86M |
| Income Before Tax Ratio | 1.44% | 2.04% | 2.39% | 2.43% | 2.53% |
| Income Tax Expense | 22.39M | 34.82M | 17.87M | 14.49M | 24.44M |
| Net Income | 37.71M | 65.55M | 65.14M | 57.94M | 65.42M |
| Net Income Ratio | 0.90% | 1.33% | 1.87% | 1.95% | 1.85% |
| EPS | 1.49 | 2.72 | 2.79 | 2.48 | 2.80 |
| EPS Diluted | 1.49 | 2.72 | 2.79 | 2.48 | 2.80 |
| Weighted Avg Shares Out | 25.39M | 24.08M | 23.38M | 23.38M | 23.38M |
| Weighted Avg Shares Out (Dil) | 25.39M | 24.08M | 23.38M | 23.38M | 23.38M |
No news found for: AREYDRG.BO
Source: https://incomestatements.info
Category: Stock Reports